ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $34,955 | -8.8% | 970,151 | 0.0% | 1.76% | +3.2% |
| Q4 2022 | $38,340 | -99.9% | 970,151 | 0.0% | 1.70% | -7.8% |
| Q3 2022 | $38,981,000 | -4.4% | 970,151 | 0.0% | 1.85% | +5.1% |
| Q2 2022 | $40,785,000 | +7.9% | 970,151 | 0.0% | 1.76% | +8.5% |
| Q1 2022 | $37,797,000 | -2.2% | 970,151 | 0.0% | 1.62% | -5.3% |
| Q4 2021 | $38,661,000 | +10.3% | 970,151 | 0.0% | 1.71% | +3.7% |
| Q3 2021 | $35,061,000 | -11.8% | 970,151 | 0.0% | 1.65% | -9.7% |
| Q2 2021 | $39,766,000 | -99.1% | 970,151 | 0.0% | 1.83% | -91.5% |
| Q1 2021 | $4,231,798,000 | +113.6% | 970,151 | -75.5% | 21.59% | -0.4% |
| Q4 2020 | $1,981,228,000 | +18.5% | 3,958,498 | -0.4% | 21.69% | +8.2% |
| Q3 2020 | $1,671,777,000 | -13.3% | 3,973,800 | 0.0% | 20.05% | -28.5% |
| Q2 2020 | $1,929,279,000 | – | 3,973,800 | – | 28.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |